Study of Alirocumab (REGN727/SAR236553) in Patients With heFH (Heterozygous Familial Hypercholesterolemia) Who Are Not Adequately Controlled With Their LMT (Lipid-Modifying Therapy)
Clinical trial NCT01709500 · COMPLETED
Trial details
- NCT number
- NCT01709500
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-01
- Primary completion
- 2014-05-01
- Enrollment
- 249
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.